Re: Antigen Her2 vaccine progress (breast and prostate)
Bird,
I think the gist of things is that they are realizing some prostate cancers, as well as ovarian and gastric, have a her2 receptor, making them targetable by her2 based therapies. I have not seen anything suggesting male her2+ breast cancer increasing risk of prostate cancer of any variety. The Provenge vaccine therapy is not Her2 based. I do like the Antigen Her2 vaccine approach since it seems to be able to target tumors with lower Her2 levels, opening it up to more (75%) BC patients.
|